336 related articles for article (PubMed ID: 17804128)
1. Transfusion-related immunomodulation (TRIM): an update.
Vamvakas EC; Blajchman MA
Blood Rev; 2007 Nov; 21(6):327-48. PubMed ID: 17804128
[TBL] [Abstract][Full Text] [Related]
2. Pneumonia as a complication of blood product transfusion in the critically ill: transfusion-related immunomodulation (TRIM).
Vamvakas EC
Crit Care Med; 2006 May; 34(5 Suppl):S151-9. PubMed ID: 16617260
[TBL] [Abstract][Full Text] [Related]
3. Possible mechanisms of allogeneic blood transfusion-associated postoperative infection.
Vamvakas EC
Transfus Med Rev; 2002 Apr; 16(2):144-60. PubMed ID: 11941576
[TBL] [Abstract][Full Text] [Related]
4. White-blood-cell-containing allogeneic blood transfusion and postoperative infection or mortality: an updated meta-analysis.
Vamvakas EC
Vox Sang; 2007 Apr; 92(3):224-32. PubMed ID: 17348871
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: the effects of the type of transfused red blood cell product and surgical setting.
Vamvakas EC
Transfus Med Rev; 2002 Oct; 16(4):304-14. PubMed ID: 12415516
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of randomized controlled trials comparing the risk of postoperative infection between recipients of allogeneic and autologous blood transfusion.
Vamvakas EC
Vox Sang; 2002 Nov; 83(4):339-46. PubMed ID: 12437521
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive effects of allogeneic blood transfusions: implications for the patient with a malignancy.
Bordin JO; Blajchman MA
Hematol Oncol Clin North Am; 1995 Feb; 9(1):205-18. PubMed ID: 7737942
[TBL] [Abstract][Full Text] [Related]
8. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
9. Leukodepletion of autologous whole blood has no impact on perioperative infection rate and length of hospital stay.
Frietsch T; Karger R; Schöler M; Huber D; Bruckner T; Kretschmer V; Schmidt S; Leidinger W; Weiler-Lorentz A
Transfusion; 2008 Oct; 48(10):2133-42. PubMed ID: 18564391
[TBL] [Abstract][Full Text] [Related]
10. Transfusion-related immunomodulation by platelets is dependent on their expression of MHC Class I molecules and is independent of white cells.
Aslam R; Speck ER; Kim M; Freedman J; Semple JW
Transfusion; 2008 Sep; 48(9):1778-86. PubMed ID: 18522705
[TBL] [Abstract][Full Text] [Related]
11. Transfusion-related immunomodulation: a second hit in an inflammatory cascade?
Bilgin YM; Brand A
Vox Sang; 2008 Nov; 95(4):261-71. PubMed ID: 19138255
[TBL] [Abstract][Full Text] [Related]
12. Transfusion immunomodulation or TRIM: what does it mean clinically?
Blajchman MA
Hematology; 2005; 10 Suppl 1():208-14. PubMed ID: 16188675
[TBL] [Abstract][Full Text] [Related]
13. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations.
Odent-Malaure H; Quainon F; Ruyer-Dumontier P; Ducroz S; Verdier P; Voitellier E; Raynal MF; Fromont P; Muller JY; Rebibo D; Absi L; Garraud O
Clin Dev Immunol; 2005 Dec; 12(4):243-8. PubMed ID: 16584109
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of transfusion-associated immunosuppression.
Blajchman MA; Bordin JO
Curr Opin Hematol; 1994 Nov; 1(6):457-61. PubMed ID: 9371323
[TBL] [Abstract][Full Text] [Related]
15. Why have meta-analyses of randomized controlled trials of the association between non-white-blood-cell-reduced allogeneic blood transfusion and postoperative infection produced discordant results?
Vamvakas EC
Vox Sang; 2007 Oct; 93(3):196-207. PubMed ID: 17845256
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation and blood transfusion.
Blajchman MA
Am J Ther; 2002; 9(5):389-95. PubMed ID: 12237730
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects of leucoreduction of blood transfusions.
Bilgin YM; van de Watering LM; Brand A
Neth J Med; 2011 Oct; 69(10):441-50. PubMed ID: 22058263
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory effects of blood transfusions: the synergic role of soluble HLA Class I free heavy-chain molecules detectable in blood components.
Ghio M; Contini P; Ubezio G; Mazzei C; Puppo F; Indiveri F
Transfusion; 2008 Aug; 48(8):1591-7. PubMed ID: 18466172
[TBL] [Abstract][Full Text] [Related]
19. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen.
Clark DA; Gorczynski RM; Blajchman MA
Transfusion; 2008 May; 48(5):814-21. PubMed ID: 18298594
[TBL] [Abstract][Full Text] [Related]
20. [Research advance on transfusion-related immunomodulation].
Zhu XF; Xia R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):268-72. PubMed ID: 20137161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
